Daiichi Sankyo Company, Limited (DSNKY)
OTCMKTS · Delayed Price · Currency is USD
19.30
+0.26 (1.37%)
Jan 29, 2026, 3:55 PM EST
Daiichi Sankyo Company Market Cap
Daiichi Sankyo Company has a market cap or net worth of $35.29 billion as of January 29, 2026. Its market cap has decreased by -32.34% in one year.
Market Cap
35.29B
Enterprise Value
33.07B
Revenue
13.37B
Ranking
n/a
PE Ratio
18.66
Stock Price
$19.30
Market Cap Chart
Since September 28, 2005, Daiichi Sankyo Company's market cap has increased from 2.93B to 35.29B, an increase of 1,105.95%. That is a compound annual growth rate of 13.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 35.29B | -11.02% |
| Dec 30, 2025 | 39.66B | -23.97% |
| Dec 30, 2024 | 52.16B | -0.97% |
| Dec 29, 2023 | 52.67B | -14.75% |
| Dec 30, 2022 | 61.78B | 26.88% |
| Dec 30, 2021 | 48.69B | -26.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 833.06M |
| Glass House Brands | 764.02M |
| Elite Pharmaceuticals | 480.43M |
| Northwest Biotherapeutics | 463.33M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 361.55M |
| CytoDyn | 320.10M |
| Tian'an Technology Group | 318.63M |